HwaGen
Latest round
- Series B
Last raised
- Dec 2022
Total raised
- $52M
Investors
- 12
About HwaGen
Founded in 2015 and based in Shenzhen, China, HwaGen is a pharmaceutical technology company that focuses on R&D of pharmaceutical APIs and intermediates. The company has 1800 square meters of R&D and office space. As of 2022, it has more than 50 employees. The company's main products include pazopani hydrochloride, veranterol triphenylacetate, dulutvir sodium salt and pharmaceutical intermediates. Its products are used in anti-tumor, anti-virus, anti-respiratory diseases and other fields.
Who invested in HwaGen
12 investors across 4 rounds
See all investors in HwaGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about HwaGen
Who invested in HwaGen?
HwaGen has 12 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HwaGen raised?
HwaGen has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did HwaGen last raise money?
HwaGen's most recent round on record is a Series B, in Dec 2022.
What does HwaGen do?
Founded in 2015 and based in Shenzhen, China, HwaGen is a pharmaceutical technology company that focuses on R&D of pharmaceutical APIs and intermediates.
Where is HwaGen headquartered?
HwaGen is headquartered in Shenzhen, China.
Which VCs invest in companies like HwaGen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at HwaGen's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like HwaGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.